Home Eli Lilly changes outcome goals in Alzheimer's drug study
 

Keywords :   


Eli Lilly changes outcome goals in Alzheimer's drug study

2016-03-15 22:32:15| Biotech - Topix.net

" Eli Lilly says it's changed the outcome goals for a late-stage patient study of its closely watched experimental drug for Alzheimer's disease, solanezumab. The Expedition3 trial had two primary outcome measures: changes in participants' cognition and their daily function.

Tags: study drug goals outcome

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.11
14.115
14.11MTGfoil
14.11
14.11sw14000XH 8000
14.11katie
14.11EX 330 HP SAR
14.11 M1
More »